Harper T W, Garrity M J, Murphy R C
J Biol Chem. 1986 Apr 25;261(12):5414-8.
Isolated rat heptocytes were found to metabolize leukotriene B4 (LTB4) to a number of products which could be separated by reverse phase high performance liquid chromatography (HPLC). After incubation of LTB4 with hepatocytes for 15 min, the known omega-oxidized metabolites, 20-hydroxy- and 20-carboxy-LTB4, were identified by HPLC retention time and gas chromatography-mass spectrometry. An early fraction corresponding to 15% of the initial LTB4 was structurally characterized as a novel metabolite, 18-carboxy-19,20-dinor-LTB4, by ultraviolet spectroscopy and gas chromatography-mass spectrometry of the derivatized and derivatized, reduced metabolite. The short HPLC retention time of this metabolite was consistent with its reduced lipophilicity. An additional minor metabolite was tentatively identified as 3-hydroxy-LTB4. These two novel metabolites provide evidence for beta-oxidation as an important route of hepatic biotransformation of LTB4 and 20-hydroxy-LTB4.
已发现分离的大鼠肝细胞可将白三烯B4(LTB4)代谢为多种产物,这些产物可通过反相高效液相色谱法(HPLC)分离。将LTB4与肝细胞孵育15分钟后,通过HPLC保留时间和气相色谱-质谱法鉴定出已知的ω-氧化代谢产物20-羟基-LTB4和20-羧基-LTB4。通过对衍生化和还原代谢产物进行紫外光谱和气相色谱-质谱分析,将对应于初始LTB4 15%的早期馏分结构表征为一种新型代谢产物18-羧基-19,20-二去甲-LTB4。该代谢产物较短的HPLC保留时间与其降低的亲脂性一致。另一种次要代谢产物初步鉴定为3-羟基-LTB4。这两种新型代谢产物为β-氧化作为LTB4和20-羟基-LTB4肝脏生物转化的重要途径提供了证据。